BioMarin Pharmaceutical Inc.
Symbol: BMRN
NASDAQ
82.44
USDMarktpreis heute
75.7836
P/E-Verhältnis
2.6945
PEG-Verhältnis
15.65B
MRK Kapital
- 0.00%
DIV Rendite
BioMarin Pharmaceutical Inc. (BMRN) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 4417.19 | 1073.8 | 1291.5 | 1013.9 | ||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 1435.28 | 318.7 | 567 | 426.6 | ||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 2453.59 | 633.7 | 461.3 | 373.4 | ||||||||||||||||||||||||||
balance-sheet.row.inventory | 4252.87 | 1107.2 | 894.1 | 776.7 | ||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 722.88 | 141.4 | 104.5 | 110.4 | ||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 11846.52 | 2956.1 | 2751.5 | 2274.4 | ||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 4260.99 | 1112.2 | 1073.4 | 1035.5 | ||||||||||||||||||||||||||
balance-sheet.row.goodwill | 784.8 | 196.2 | 196.2 | 196.2 | ||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 1187.17 | 294.7 | 338.6 | 388.7 | ||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1971.97 | 490.9 | 534.8 | 584.9 | ||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 2165.47 | 615.4 | 333.8 | 507.8 | ||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 6125.1 | 1545.8 | 1505.4 | 1449.1 | ||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 665.56 | 121.2 | 176.2 | 151.8 | ||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 15189.09 | 3885.5 | 3623.6 | 3728.9 | ||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.total-assets | 27035.61 | 6841.6 | 6375.1 | 6003.3 | ||||||||||||||||||||||||||
balance-sheet.row.account-payables | 1856 | 315.5 | 231.2 | 193 | ||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 1489.93 | 502.7 | 10.4 | 10.5 | ||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 38.28 | 2.7 | 16.2 | 3.1 | ||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 2864.28 | 593.1 | 1083 | 1079.1 | ||||||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 2543.75 | 354.2 | 346.6 | 329.4 | ||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 3305.14 | 713 | 1183 | 1192.8 | ||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 1059.32 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 64.32 | 38.1 | 10.4 | 10.5 | ||||||||||||||||||||||||||
balance-sheet.row.total-liab | 7330.52 | 1890.1 | 1771.9 | 1732.6 | ||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.common-stock | 0.76 | 0.2 | 0.2 | 0.2 | ||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | -2478.68 | -621.6 | -789.2 | -925.7 | ||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -53.89 | -38.6 | -3.9 | 14.4 | ||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 22236.91 | 5611.6 | 5396 | 5181.8 | ||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 19705.09 | 4951.5 | 4603.2 | 4270.7 | ||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 27035.61 | 6841.6 | 6375.1 | 6003.3 | ||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.total-equity | 19705.09 | 4951.5 | 4603.2 | 4270.7 | ||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 27035.61 | - | - | - | ||||||||||||||||||||||||||
Total Investments | 2980.19 | 934.1 | 900.8 | 934.4 | ||||||||||||||||||||||||||
balance-sheet.row.total-debt | 4345.91 | 1133.9 | 1083 | 1079.1 | ||||||||||||||||||||||||||
balance-sheet.row.net-debt | 1363.99 | 378.7 | 358.5 | 491.8 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 205.46 | 167.6 | 141.6 | -64.1 | ||||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 105.31 | 104.4 | 102 | 108 | ||||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | -38.34 | -45 | -52.1 | -15.6 | ||||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 211.65 | 207099 | 196.3 | 197.3 | ||||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | -225.28 | -336.5 | -96.4 | 66 | ||||||||||||||||||||||||||
cash-flows.row.account-receivables | -55.02 | -190.4 | -82 | 65.6 | ||||||||||||||||||||||||||
cash-flows.row.inventory | -159.78 | -157.1 | -68.3 | -35.1 | ||||||||||||||||||||||||||
cash-flows.row.account-payables | 41.53 | 68.9 | 59 | 15689 | ||||||||||||||||||||||||||
cash-flows.row.other-working-capital | -52.01 | -57.9 | -5.1 | -15653.5 | ||||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 616.91 | -206830.3 | -115.5 | 12.9 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 280.16 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -116.95 | -107.6 | -131.5 | -119.2 | ||||||||||||||||||||||||||
cash-flows.row.acquisitions-net | -27.05 | 10920 | 0 | -23.6 | ||||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -769.8 | -868.5 | -611.8 | -937.1 | ||||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 781.28 | 864.9 | 620 | 691 | ||||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 37.05 | -10920 | 103.3 | 22.7 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -95.47 | -111.2 | -20 | -366.3 | ||||||||||||||||||||||||||
cash-flows.row.debt-repayment | -1.31 | -2.3 | -2.6 | -3 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 55.38 | 69.4 | 69.3 | 49.2 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -74.84 | 0 | -54.3 | -45.8 | ||||||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -15.1 | -3.4 | ||||||||||||||||||||||||||
cash-flows.row.other-financing-activites | -32.89 | -85.8 | -16 | 3 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -20.78 | -18.7 | -18.6 | 0 | ||||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 1978.77 | 1308 | 0 | -0.1 | ||||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 166.92 | 30.6 | 137.3 | -61.9 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 2981.92 | 755.1 | 724.5 | 587.3 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 2815 | 724.5 | 587.3 | 649.2 | ||||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 280.16 | 159.3 | 175.9 | 304.5 | ||||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -116.95 | -107.6 | -131.5 | -119.2 | ||||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 163.21 | 51.6 | 44.4 | 185.3 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 2475.6 | 2419.2 | 2096 | 1846.3 | ||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 559.06 | 577.1 | 483.7 | 470.5 | ||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 1916.54 | 1842.2 | 1612.4 | 1375.8 | ||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
income-statement-row.row.research-development | 779.91 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 343.64 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 370.7 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.other-expenses | 196.88 | -10.5 | 67.2 | 69.9 | ||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 1740.86 | 1684.6 | 1570.8 | 1458.1 | ||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 2299.92 | 2261.6 | 2054.5 | 1928.6 | ||||||||||||||||||||||||||
income-statement-row.row.interest-income | 65.76 | 58.3 | 18 | 10.5 | ||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 17.18 | 17.3 | 16 | 15.3 | ||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 370.7 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 61.67 | 31 | 92 | -15.3 | ||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 196.88 | -10.5 | 67.2 | 69.9 | ||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 61.67 | 31 | 92 | -15.3 | ||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 17.18 | 17.3 | 16 | 15.3 | ||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 105.31 | 104.4 | 102 | 108 | ||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 281 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.operating-income | 175.68 | 157.6 | 57.5 | -60 | ||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 237.35 | 188.6 | 149.6 | -75.3 | ||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 31.9 | 20.9 | 8 | -11.3 | ||||||||||||||||||||||||||
income-statement-row.row.net-income | 205.46 | 167.6 | 141.6 | -64.1 |
Häufig gestellte Frage
Wie hoch ist die BioMarin Pharmaceutical Inc. (BMRN) Gesamtvermögen?
BioMarin Pharmaceutical Inc. (BMRN) Gesamtvermögen ist 6841603000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist 1295040000.000.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.774.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist 0.864.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.083.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.071.
Was ist der BioMarin Pharmaceutical Inc. (BMRN) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist 167645000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 1133875000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 1684564000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 746996000.000.